Effect of anti-transforming growth factor-βbgr; antibodies in cyclosporine-induced renal dysfunction
- 1 February 2001
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 59 (2), 498-506
- https://doi.org/10.1046/j.1523-1755.2001.059002498.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- TRANSFORMING GROWTH FACTOR-?? LEVELS IN HUMAN ALLOGRAFT CHRONIC FIBROSIS CORRELATE WITH RATE OF DECLINE IN RENAL FUNCTION1Transplantation, 1999
- TRANSFORMING GROWTH FACTOR (TGF)-?? MIMICS AND ANTI-TGF-?? ANTIBODY ABROGATES THE IN VIVO EFFECTS OF CYCLOSPORINETransplantation, 1999
- Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathyKidney International, 1998
- Angiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathyKidney International, 1997
- Sodium depletion enhances fibrosis and the expression of TGF-β1 and matrix proteins in experimental chronic cyclosporine nephropathyAmerican Journal of Kidney Diseases, 1997
- Transforming Growth Factor-β1 Inhibits Type I Inositol 1,4,5-Trisphosphate Receptor Expression and Enhances Its Phosphorylation in Mesangial CellsJournal of Biological Chemistry, 1997
- Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicityKidney International, 1996
- CYCLOSPORINE STIMULATES EXPRESSION OF TRANSFORMING GROWTH FACTOR-β IN RENAL CELLS POSSIBLE MECHANISM OF CYCLOSPORINES ANTIPROLIFERATIVE EFFECTSTransplantation, 1995
- Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles.JCI Insight, 1993
- Spontaneous renal neoplasms in ratsJournal of Applied Toxicology, 1993